AI Summary
The Ohio Hematopoietic Transplant and Cellular Therapy Consortium, with EIN 31-1340154, is dedicated to ensuring that all Ohio residents have access to quality care for hematologic malignancies, particularly cancers and musculoskeletal diseases. Operating with a budget of $104.4K and total revenue of $87.6K for the 2024 filing year, the organization plays a vital role in the healthcare landscape of Ohio. It does not appear to rely on a single funder for 50% or more of its revenue.
Mission Statement
TO ENSURE ALL OHIO RESIDENTS HAVE ACCESS TO QUALITY CARE FOR HEMATOLOGIC MALIGNANCIES.
Cause Areas
2
Musculoskeletal diseases
Cancers
Explore this org's ecosystem
See similar nonprofits by cause and location, their funders, and their grants.
Explore this org's ecosystem
See similar nonprofits by cause and location, their funders, and their grants.
Charity Verification Snapshot
IRS EO Business Master File Status
Listed as tax-exempt
IRS Pub 78 Status
Eligible for tax-deductible gifts
IRS Revocation Status
Not in Automatic Revocation of Exemption List
Go beyond basic verification
Instantly get 50+ financial health and governance metrics, including LUNA.
Go beyond basic verification
Instantly get 50+ financial health and governance metrics, including LUNA.
Frequently Asked Questions
What is OHIO HEMATOPOIETIC TRANSPLANT AND CELLULAR THERAPY CONSORTIUM’s budget?
In 2024, OHIO HEMATOPOIETIC TRANSPLANT AND CELLULAR THERAPY CONSORTIUM reported an annual operating budget of around $104 thousand. More detailed financial information is available to registered users.
What causes does OHIO HEMATOPOIETIC TRANSPLANT AND CELLULAR THERAPY CONSORTIUM support?
OHIO HEMATOPOIETIC TRANSPLANT AND CELLULAR THERAPY CONSORTIUM supports work in Musculoskeletal diseases and Cancers.
Where does OHIO HEMATOPOIETIC TRANSPLANT AND CELLULAR THERAPY CONSORTIUM operate?
OHIO HEMATOPOIETIC TRANSPLANT AND CELLULAR THERAPY CONSORTIUM is headquartered in Galena, OH.